Cargando…
Significant pharmaceuticals reported in recent US patents /
This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the sign...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; London :
Elsevier,
2007.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn162131457 | ||
| 003 | OCoLC | ||
| 005 | 20231117014903.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070802s2007 ne a ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d OPELS |d OCLCQ |d N$T |d YDXCP |d MERUC |d E7B |d IDEBK |d OCLCQ |d OCLCF |d OCLCQ |d D6H |d UAB |d OCLCQ |d WYU |d OCLCQ |d OCLCO |d LEAUB |d OL$ |d OCLCA |d S2H |d OCLCO |d OCLCQ |d OCLCO |d INARC |d OCLCQ |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 015 | |a GBA700268 |2 bnb | ||
| 016 | 7 | |a 101392576 |2 DNLM | |
| 016 | 7 | |a 013633580 |2 Uk | |
| 019 | |a 154024784 |a 441804519 |a 648300459 |a 1066558868 |a 1256501662 | ||
| 020 | |a 9780080453446 | ||
| 020 | |a 0080453449 | ||
| 020 | |a 9780080480916 |q (electronic bk.) | ||
| 020 | |a 0080480918 |q (electronic bk.) | ||
| 035 | |a (OCoLC)162131457 |z (OCoLC)154024784 |z (OCoLC)441804519 |z (OCoLC)648300459 |z (OCoLC)1066558868 |z (OCoLC)1256501662 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RM301.25 |b .D47 2007 | |
| 060 | 4 | |a 2007 M-406 | |
| 060 | 4 | |a QV 25 |b D437s 2007 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.1900973 |2 22 |
| 100 | 1 | |a DeRosa, Thomas F. | |
| 245 | 1 | 0 | |a Significant pharmaceuticals reported in recent US patents / |c Thomas F. DeRosa. |
| 260 | |a Amsterdam ; |a London : |b Elsevier, |c 2007. | ||
| 300 | |a 1 online resource (xx, 680 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents | ||
| 505 | 0 | |a Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus. | |
| 500 | |a Includes index. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Drugs |x Research |z United States. | |
| 650 | 0 | |a Drugs |z United States |x Patents. | |
| 650 | 0 | |a Drug development |z United States. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Drugs |x Patients |z United States. | |
| 650 | 1 | 2 | |a Pharmaceutical Preparations |x analysis |0 (DNLM)D004364Q000032 |
| 650 | 1 | 2 | |a Pharmaceutical Preparations |x chemistry |0 (DNLM)D004364Q000737 |
| 650 | 2 | 2 | |a Drug Design |0 (DNLM)D015195 |
| 651 | 2 | |a United States |0 (DNLM)D014481 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0042439 |x Recherche |0 (CaQQLa)201-0042439 |z �Etats-Unis. |0 (CaQQLa)201-0407727 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0002990 |x Patients |0 (CaQQLa)201-0380423 |z �Etats-Unis. |0 (CaQQLa)201-0407727 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0306620 |x D�eveloppement |0 (CaQQLa)201-0306620 |z �Etats-Unis. |0 (CaQQLa)201-0407727 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0002990 |z �Etats-Unis |0 (CaQQLa)201-0407727 |x Brevets d'invention. |0 (CaQQLa)201-0378421 | |
| 650 | 6 | |a M�edicaments |x Conception. |0 (CaQQLa)201-0203461 | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Design |2 fast |0 (OCoLC)fst00898790 | |
| 650 | 7 | |a Drug development |2 fast |0 (OCoLC)fst00898670 | |
| 650 | 7 | |a Drugs |2 fast |0 (OCoLC)fst00898761 | |
| 650 | 7 | |a Drugs |x Research |2 fast |0 (OCoLC)fst00898894 | |
| 651 | 7 | |a United States |2 fast |0 (OCoLC)fst01204155 | |
| 655 | 2 | |a Laboratory Manual |0 (DNLM)D020484 | |
| 655 | 7 | |a patents. |2 aat |0 (CStmoGRI)aatgf300027832 | |
| 655 | 7 | |a Laboratory manuals |2 fast |0 (OCoLC)fst01920776 | |
| 655 | 7 | |a Patents |2 fast |0 (OCoLC)fst01423842 | |
| 655 | 7 | |a Patents. |2 lcgft | |
| 655 | 7 | |a Laboratory manuals. |2 lcgft | |
| 655 | 7 | |a Manuels de laboratoire. |2 rvmgf |0 (CaQQLa)RVMGF-000001214 | |
| 655 | 7 | |a Brevets d'invention. |2 rvmgf |0 (CaQQLa)RVMGF-000001468 | |
| 776 | 0 | 8 | |i Print version: |a DeRosa, Thomas F. |t Significant pharmaceuticals reported in recent US patents. |d Amsterdam ; London : Elsevier, 2007 |z 9780080453446 |z 0080453449 |w (OCoLC)77540482 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780080453446 |z Texto completo |